From: Prognostic relevance of LGALS3BP in human colorectal carcinoma
Hazard ratio | 95% CI | P | |
---|---|---|---|
Disease free survival | |||
Gender (female vs. male) | 1.06 | 0.62–1.79 | 0.84 |
Location (rectum vs. colon) | 1.49 | 0.82–2.73 | 0.19 |
Tumor grade (2–3 vs. 1) | 1.73 | 0.54–5.54 | 0.36 |
LGALS3BP (low vs. high) | 2.80 | 1.27–6.18 | 0.011 |
Overall survival | |||
Gender (female vs. male) | 1.11 | 0.61–2.03 | 0.74 |
Location (rectum vs. colon) | 1.52 | 0.77–3.02 | 0.23 |
Tumor grade (2–3 vs. 1) | 1.84 | 0.44–7.61 | 0.40 |
LGALS3BP (low vs. high) | 4.07 | 1.45–11.45 | 0.008 |